• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNG:FP

8.4000 EUR 0.2900 3.34%

As of 11:35:00 ET on 07/31/2014.

Company Profile for Transgene SA (TNG)

Transgene S.A. is a biotechnology company. The Company develops vaccines against cancer and infectious diseases. Transgene has products under development for lung, kidney, prostate and colorectal cancers, cutaneous T-cell lymphoma, hepatitis C, malignant melanoma, and muscular dystrophy.

Contact Information

Transgene SA

Boulevard Gonthier
Andernach Parc
Illkirch, 67403
France
Phone: 33-3-88-27-91-00
Fax: 33-3-88-27-91-11

Key Executives for Transgene SA (TNG)

Philippe ArchinardChairman/CEOStephane BoisselExecutive Vice President
Laurence BertaudDir:Human ResourcesNathalie AddaDir:Regulatory Affairs
Patrick MahieuxDir:Industrial OperationsThibaut Du FayetDir:Licensing & Mktg
Colin FreundDir:Business DevElisabetta CastelliDir:Investor Relations
Ghislaine GilleronGeneral Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil